newsfilter
← Latest News
ACCESS Newswire·

Hemogenyx Pharmaceuticals Announces CDX Licence Agreement

LONDON, UK / ACCESSWIRE / October 13, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that it has signed a licence agreement (the "Agreement") with the glo